Cargando…

Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE)

BACKGROUND: The prevention of coronavirus disease 2019 (COVID-19) in vulnerable populations is a global health priority. EVADE was a phase 2/3 multicenter, double-blind, randomized, placebo-controlled trial of adintrevimab, an extended–half-life monoclonal antibody, for postexposure (PEP) and pre-ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ison, Michael G, Weinstein, Debra F, Dobryanska, Marta, Holmes, Anna, Phelan, Anne-Marie, Li, Yong, Gupta, Deepali, Narayan, Kristin, Tosh, Kazima, Hershberger, Ellie, Connolly, Lynn E, Yalcin, Ilker, Campanaro, Ed, Hawn, Pamela, Schmidt, Pete
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10368201/ https://www.ncbi.nlm.nih.gov/pubmed/37496612 http://dx.doi.org/10.1093/ofid/ofad314

Ejemplares similares

Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
por: Ison, Michael G, et al.
Publicado: (2023)

Safety, Pharmacokinetics, Serum Neutralizing Titers, and Immunogenicity of Adintrevimab, a Monoclonal Antibody Targeting SARS-CoV-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Dose-escalation Study in Healthy Adults
por: Schmidt, Pete, et al.
Publicado: (2023)

633. Preliminary Results from a Phase 1 Single Ascending-Dose Study Assessing Safety, Serum Viral Neutralizing Antibody Titers (sVNA), and Pharmacokinetic (PK) Profile of ADG20: an Extended Half-Life Monoclonal Antibody Being Developed for the Treatment and Prevention of Coronavirus Disease (COVID-19)
por: Paguntalan, Helen, et al.
Publicado: (2021)

Nicolau Syndrome: An Unforeseen Yet Evadable Consequence of Intramuscular Injection
por: Sasmal, Prakash K., et al.
Publicado: (2021)

Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19
por: Zumbrun, Elizabeth E., et al.
Publicado: (2022)

1363. Preliminary Safety Results from a Phase 1 First in Human Study of VYD222: an Extended Half-Life Monoclonal Antibody (mAb) in Development for COVID-19 Prevention
por: Mahoney, Kathryn, et al.
Publicado: (2023)

Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults
por: Assantachai, Prasert, et al.
Publicado: (2023)

Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results( )
por: Withanage, Kanchanamala, et al.
Publicado: (2021)

Side-by-side Comparative Study of the Immunogenicity of the Intramuscular and Intradermal Rabies Post-exposure Prophylaxis Regimens in a Cohort of Suspected Rabies Virus Exposed Individuals
por: Auerswald, Heidi, et al.
Publicado: (2023)

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial
por: Shapiro, Adrienne E, et al.
Publicado: (2023)

Has the tobacco industry evaded the FDA's ban on ‘Light’ cigarette descriptors?
por: Connolly, Gregory N, et al.
Publicado: (2014)

Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial
por: Bunjun, Rubina, et al.
Publicado: (2022)

Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
por: Kumar, Rebecca N, et al.
Publicado: (2021)

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
por: Kim, Jin Yong, et al.
Publicado: (2022)

Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs Conundrums
por: Goldstein, Ellie J C, et al.
Publicado: (2020)

E-cadherin evades endocytosis
por: LeBrasseur, Nicole
Publicado: (2004)

Frog oocytes evade the checkpoint
por: Short, Ben
Publicado: (2013)

Evading resistance to gene drives
por: Gomulkiewicz, Richard, et al.
Publicado: (2021)

Endothelial Activation and Repair During Hantavirus Infection: Association with Disease Outcome
por: Connolly-Andersen, Anne-Marie, et al.
Publicado: (2014)

Examining the accuracy of residents’ self-assessments and faculty assessment behaviours in anesthesiology
por: Fleming, Melinda, et al.
Publicado: (2021)

A Downward Trend of the Ratio of Influenza RNA Copy Number to Infectious Viral Titer in Hospitalized Influenza A-Infected Patients
por: Van Wesenbeeck, Liesbeth, et al.
Publicado: (2015)

Individual variation evades the Prisoner's Dilemma
por: Johnson, Dominic DP, et al.
Publicado: (2002)

Bacterial Cheaters Evade Punishment by Cyanide
por: Smith, Parker, et al.
Publicado: (2019)

Evading the AAV Immune Response in Mucopolysaccharidoses
por: Piechnik, Matthew, et al.
Publicado: (2020)

Omicron evades immunity from vaccines
por: Onuora, Sarah
Publicado: (2022)

Variation in Tularemia Clinical Manifestations—Arkansas, 2009–2013
por: Lester Rothfeldt, Laura K., et al.
Publicado: (2017)

A Phase 2 Study of Pimodivir (JNJ-63623872) in Combination With Oseltamivir in Elderly and Nonelderly Adults Hospitalized With Influenza A Infection: OPAL Study( )
por: O’Neil, Brian, et al.
Publicado: (2020)

Predicting Carbapenem-Resistant Enterobacteriaceae Carriage at the Time of Admission Using a Statewide Hospital Discharge Database
por: Lin, Michael Y, et al.
Publicado: (2019)

Buprenorphine for postoperative analgesia: Axillary brachial plexus block versus intramuscular administration in a placebo-controlled trial
por: Thakur, Deepali, et al.
Publicado: (2015)

The Canada-Guyana medical education partnership: using videoconferencing to supplement post-graduate medical education among internal medicine trainees
por: Stokes, William, et al.
Publicado: (2017)

Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003–2013
por: Shah, Neha S., et al.
Publicado: (2016)

Non-toxic antimicrobials that evade drug resistance
por: Davis, Stephen A., et al.
Publicado: (2015)

Fungal Strategies to Evade the Host Immune Recognition
por: Hernández-Chávez, Marco J., et al.
Publicado: (2017)

Tools of Aggregatibacter actinomycetemcomitans to Evade the Host Response
por: Oscarsson, Jan, et al.
Publicado: (2019)

Transgender medicalization and the attempt to evade psychological distress
por: Withers, Robert
Publicado: (2020)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Genomic Analysis of Community Transmission Networks for MRSA Among Females Entering a Large Inner-city Jail
por: Popovich, Kyle J, et al.
Publicado: (2022)

Private Practice Dentists Improve Antibiotic Use After Dental Antibiotic Stewardship Education From Infectious Diseases Experts
por: Goff, Debra A, et al.
Publicado: (2022)

Duration of Colonization With Klebsiella pneumoniae Carbapenemase-Producing Bacteria at Long-Term Acute Care Hospitals in Chicago, Illinois
por: Haverkate, Manon R., et al.
Publicado: (2016)

A Clinical Prediction Tool for Extended-Spectrum Cephalosporin Resistance in Community-Onset Enterobacterales Urinary Tract Infection
por: Weinstein, Erica J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m8q52is9tr4uv61urqaq22laqr